p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability
Linda Fabris1, Stefania Berton1, Ilenia Pellizzari1
1Division of Experimental Oncology 2, Department of Translational Research, Centro di Riferimento Oncologico (CRO Aviano), National Cancer Institute, 33081 Aviano, Italy;
Abstract:
The cyclin-dependent kinase (CDK) inhibitor p27(kip1) is a critical regulator of the G1/S-phase transition of the cell cycle and also regulates microtubule (MT) stability. This latter function is exerted by modulating the activity of stathmin, an MT-destabilizing protein, and by direct binding to MTs. We recently demonstrated that increased proliferation in p27(kip1)-null mice is reverted by concomitant deletion of stathmin in p27(kip1)/stathmin double-KO mice, suggesting that a CDK-independent function of p27(kip1) contributes to the control of cell proliferation. Whether the regulation of MT stability by p27(kip1) impinges on signaling pathway activation and contributes to the decision to enter the cell cycle is largely unknown. Here, we report that faster cell cycle entry of p27(kip1)-null cells was impaired by the concomitant deletion of stathmin. Using gene expression profiling coupled with bioinformatic analyses, we show that p27(kip1) and stathmin conjunctly control activation of the MAPK pathway. From a molecular point of view, we observed that p27(kip1), by controlling MT stability, impinges on H-Ras trafficking and ubiquitination levels, eventually restraining its full activation. Our study identifies a regulatory axis controlling the G1/S-phase transition, relying on the regulation of MT stability by p27(kip1) and finely controlling the spatiotemporal activation of the Ras-MAPK signaling pathway.
Insights
The cell cycle regulator p27(kip1) controls cell proliferation by stabilizing microtubules and influencing Ras-MAPK signaling. Deleting stathmin impairs p27(kip1)
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The cyclin-dependent kinase (CDK) inhibitor p27(kip1) is a key regulator of cell cycle progression and microtubule (MT) stability.
- p27(kip1) modulates MT stability via stathmin interaction and direct MT binding.
- Previous studies suggest a CDK-independent role for p27(kip1) in cell proliferation control.
Purpose of the Study:
- To investigate the impact of p27(kip1)-mediated MT stability on cell cycle entry and signaling pathways.
- To elucidate the molecular mechanisms by which p27(kip1) and stathmin regulate cell proliferation.
- To identify the role of the p27(kip1)-stathmin axis in Ras-MAPK pathway activation.
Main Methods:
- Gene expression profiling and bioinformatic analyses.
- Studies using p27(kip1)-null and p27(kip1)/stathmin double-knockout (KO) mouse models.
- Analysis of H-Ras trafficking and ubiquitination levels.
Main Results:
- Concomitant deletion of stathmin impaired faster cell cycle entry in p27(kip1)-null cells.
- p27(kip1) and stathmin were found to jointly control MAPK pathway activation.
- p27(kip1) regulates H-Ras trafficking and ubiquitination, thereby restraining its activation through MT stability control.
Conclusions:
- p27(kip1) controls G1/S-phase transition via MT stability and Ras-MAPK signaling.
- The p27(kip1)-stathmin interaction fine-tunes the spatiotemporal activation of the Ras-MAPK pathway.
- This study reveals a novel regulatory axis impacting cell cycle progression and signaling.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
MAPK Signaling Cascades
The Ras Gene
Ras is a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway


